Preclinical Targeting of the PGRMC1-CK2 Axis with Silmitasertib: A Potential Strategy for Lung Adenocarcinoma Therapy.
| Autor: | Solaipriya, S., Anbalagan, M, Sivaramakrishnan, V. |
|---|---|
| Zdroj: | Drug Research; Apr2024, Vol. 74 Issue 4, p187-190, 4p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|